Tasso Launches Integrated Population Pharmacokinetic Solutions to Optimize, Scale, and Accelerate Decentralized Clinical Trials

Tasso Launches Integrated Population Pharmacokinetic Solutions to Optimize, Scale, and Accelerate Decentralized Clinical Trials




Tasso Launches Integrated Population Pharmacokinetic Solutions to Optimize, Scale, and Accelerate Decentralized Clinical Trials

New integrated Tasso PopPK Solutions provide pharmaceutical companies with a seamless workflow for accurate acquisition of PopPK data

SEATTLE–(BUSINESS WIRE)–#Virtualcare–Tasso, Inc., a leader in clinical-grade blood collection solutions, today announced the launch of Tasso PopPK Solutions, an integrated patient-centric offering for population pharmacokinetics (PopPK). With the launch of Tasso PopPK Solutions, Tasso now enables pharmaceutical companies to operationalize pharmacokinetic studies as part of their decentralized clinical trial efforts. Tasso’s remote solution supports the scalable and convenient acquisition of pharmacokinetic data, improving modeling accuracy and accelerating clinical trials.

PopPK is a well-established mathematical modeling methodology for understanding the observed variability in circulating drug concentrations among individuals. Tasso’s PopPK Solutions combine the company’s signature blood collection devices with the data monitoring solutions required for accurate pharmacokinetic (PK) modeling, including timestamping, customizable patient engagement tools, and chain-of-custody monitoring. The patient-centric, virtually painless sample collection process can help to improve recruitment and retention by enhancing user experience, which leads to increased data density and fidelity.

“Our pharma partners have been seeking decentralized solutions to enhance their study adherence and to facilitate inclusion of more diverse populations,” said Erwin Berthier, PhD, CTO and co-founder of Tasso. “Tasso is uniquely positioned to deliver accurate, patient-centric sampling for PopPK studies, at home or in the research clinic. With the launch of our dedicated PopPK Solutions, programs can efficiently operationalize remote sampling.”

Through the turnkey Tasso PopPK Solution, clients can access Tasso-compatible supporting services for PopPK including remote dosing, bioanalysis, and modeling. Tasso’s solutions are designed as a modular architecture that can also incorporate components and vendors preferred by pharma partners, enabling flexible integration. For more information on Tasso PopPK solutions, please visit www.tassoinc.com/PopPK.

About Tasso

Trusted diagnostics made easy. Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.

Contacts

Dina Schneider

(206) 822-4186 x1016

media@tassoinc.com